Heatwurx Inc.
PCSA Healthcare Biotechnology
In the quarter to June 2026, EPS grew 81.0% and free cash flow grew 20.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow PCSA
Heatwurx Inc. (PCSA) Altman Z-score
Heatwurx Inc.'s Altman Z-score for fiscal 2015 is −251.45, in the distress zone (below 1.81).
Altman Z-score, annual
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2015 | −251.45 | — |
How fiscal 2015’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | (18.97) | — | −22.77 | |
| Retained earnings / total assets | (142.61) | — | −199.66 | |
| EBIT / total assets | (9.47) | — | −31.23 | |
| Market value of equity / total liabilities | 1.88 | — | 1.13 | |
| Sales / total assets | 1.09 | — | 1.09 | |
| Altman Z-score | Distress zone | −251.45 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Distress zone | −653.99 | ||
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| CDIO Cardio Diagnostics Holdings, Inc. compare | −3.6× |
| CELZ Creative Medical Technology Holdings, Inc. compare | −4.3× |
| JAGX Jaguar Animal Health, Inc. compare | −18.9× |
| ADTX Aditxt, Inc. compare | −22.3× |
| LGVN Longeveron Inc. compare | −24.1× |
| XBIO Xenetic Biosciences, Inc. compare | −30.9× |
| PCSA Heatwurx Inc. | −251× |
| NRSN NeuroSense Therapeutics Ltd. compare | — |
| RVPH Reviva Pharmaceuticals Holdings, Inc. compare | — |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets